BioSpace News Archive

VYNE Therapeutics Inc. today announced results from the Phase 2a segment of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (“AD”).

Lexaria Bioscience Corp. is pleased to announce that it has received a positive full written response from the Food and Drug Administration from its pre-Investigational New Drug (“Pre-IND”) meeting regarding DehydraTECH-CBD for the treatment of hypertension.

Peel Therapeutics has initiated a first-in-human clinical study of PEEL-224 in patients with advanced solid tumors.

BiondVax Pharmaceuticals Ltd. announced the successful conclusion of negotiations and formal approval by the European Investment Bank of new terms of its outstanding €24 million loan to BiondVax.

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) has announced the publication of Gallup’s analysis of results from Take Charge of Canine Cancer, the first-ever nationally representative survey of U.S. dog owners’ experiences with the disease.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE (roflumilast) cream 0.3% for topical use is now available in the United States for the treatment of plaque psoriasis in people aged 12 and older.

Aro Biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease.

NxGen MDx begins offering testing in Michigan and Chicago, IL for monkeypox, shingles, and lesion-forming STIs including chancroid, syphilis, and herpes.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded a research team led by Dan Merenstein, MD, professor of family medicine at Georgetown’s School of Medicine and professor of human science at the School of Health and Nawar M. Shara, PhD, director of Center of Biostatistics, Informatics and Data Science (CBIDS) at the MedStar Health Research Institute, a $23.6 million research grant to study treatments for acute rhinosinusitis.

Specialty cancer diagnostics company Precipio, Inc., welcomes Toni-Ann Mills as the Company’s Senior Director for Learning & Development.